By using, you agree to our terms and use of cookies to enhance your experience.

Leading nurse consultant joins medical technology advisory board

By Editor
8th July 2020

Leading diabetes nurse consultant Debbie Hicks has joined a medtech start-up to advise on the further development of its remote diabetes management technology platforms.

The co-founder of Trend Diabetes will help Gendius develop a range of remote management platforms for diabetes, including Intellin®, which is now the world’s fastest-growing diabetes management app with more than 235,000 downloads worldwide.

Unlike many other diabetes tracking apps, Intellin® highlights users’ risk profiles, to help users to plan for the future, and reduce their risk of developing complications.

Debbie said: “I am delighted to join Gendius’ Advisory Board. They have many exciting plans within diabetes care and for people with diabetes, both in the UK and farther afield, which I look forward to being a part of.

“I have been remotely managing people with diabetes for a very long time, and this has obviously increased hugely in the past three months due to COVID-19. It is increasingly clear that people need to be able to access information and advice when it suits them, and advances in technology are now making this possible. I fully subscribe to what Gendius is trying to achieve, and I look forward to their future progress.”

Debbie has worked in diabetes nursing since 1990, and is currently Nurse Consultant – Diabetes at Medicus Health Partners, working to improve diabetes care delivery across a group of 15 GP practices in Enfield. She was Editor-in-Chief of the Journal of Diabetes Nursing from 2007 to 2017, and is currently an editorial board member of The Diabetes Times.

Gendius CEO, Rory Cameron, said: ““We are delighted that Debbie has agreed to join our advisory board. Her vast experience and knowledge of diabetes care will be invaluable to us and the future development of our remote diabetes management platforms. Diabetes nursing is an incredibly important part of diabetes care, and so it was especially important for us to make sure that it was represented in our advisory team.”

Comments (0)

Register an account or login to comment